The industry is now mid-cap semiconductor stock Aehr Test Systems NASDAQ: AEHR continued to rise in 2026. For the year, shares of this semiconductor test equipment company have risen more than 400%. This allowed the company’s market capitalization to increase from about $600 million in early 2026 to about $3.5 billion.
The company’s general order announcements have been key to the stock’s rise, while general semiconductor strength has also helped. Notably, Aehr recently found its latest strength in the combination of these two factors, adding more fuel to the fire after two months without announcing new orders.
Despite this positive business development, Aehr’s current financials show a significant difference in its valuation. With this, the question going forward is whether this stock has outperformed its skis.
Aehr Announces Next Order From Virtual Customer
In mid-April, Aehr said it received a record $41 billion in production from its flagship hyperscale customer. This order is related to Sonoma’s standard package deal system. In semiconductor manufacturing, many chips are built on a single large wafer. It is then cut individually from that basin and placed in protective bags. This is the stage where Sonoma tests the chips.
After a relative silence of two months, the company made its new announcement in mid-June. According to Aehr, the company “received a follow-up production order for the FOX-XP automatic wafer-level burn-in system.”
FOX-XP performs tests on the wafer front stage, putting the entire wafer under stressful conditions to check for defects. This distinction is important to understand because the orders for both Sonoma and FOX-XP show that Aehr acquires customers at multiple stages of the production process.
Aehr added that the FOX-XP order comes from “a global leader in network products and solutions and a major supplier in the optical data transceiver market.” This is interesting because optical transceivers are seeing an increase in demand.
Optical transceivers enable high-speed data transmission over long distances, which is even more important as data centers expand and process more information. The latest estimates say optical transceiver sales are up 70% year over year to $18 billion. By acquiring customers here, Aehr can benefit from high growth rates in this space.
Aehr: New Small Order, High Rating
Despite these advantages, it should be noted that the order is not large by any means. It’s for one FOX-XP edition only, or indeed a small order that the company could announce. However, Aehr also said the customer has provided “a forecast of additional plans this calendar year as they increase capacity to support hyperscale data center deployments.”
Another positive was Aehr noting that more than 25 total customers have installed FOX-XP so far. This indicates a strong level of diversity among its customer base, although the actual breakdown of sales among them is unknown. On the day of the news, Aehr’s stock rose nearly 7%. Semiconductor energy has also been added to the mix, with the iShares Semiconductor ETF NASDAQ: SOXX up about 1.4%.
Aehr Test Systems (AEHR) price chart for Friday, June 19, 2026
As noted, Aehr has now risen to a market capitalization of close to $3.5 billion. Meanwhile, the company generated only $10.3 million in revenue last quarter. Over the next 12 months, analysts expect the company to generate revenue of approximately $82 million. This implies a forward price-to-sales ratio (P/S) of about 43x. That figure is more than four times its average forward P/S ratio of 10x over the past three years. Additionally, for the next 12 months, analysts expect Aehr to generate negative operating income.
This comes as, despite the company announcing more orders, its sales and profit metrics are yet to improve. Notably, revenue fell 44% year-on-year (YOY) in its most recent quarter. Meanwhile, its adjusted earnings per share fell from 7 cents to 5 cents. On the other hand, its backlog reached a record $50.9 million, which came before its track record of $41 million in April. Although Aehr’s finances are experiencing difficulties today, these statistics point to significant improvements going forward.
Aehr: Investors Wait for Funds to Reach Analysis
Aehr’s estimation creates real room for concern. Still, the company is undoubtedly generating strong interest in its products, and it’s entirely possible that more order announcements are on the way. These factors repeat the high risk-reward setup of Aehr stock.
Ultimately, seeing orders translate into actual sales and improved profits will be key going forward. The company will have another chance to demonstrate this in its next earnings report, based on its previous release, due in July.
Before you consider Aehr Test Systems, you’ll want to hear this.
MarketBeat tracks Wall Street’s top and most effective research analysts and the stocks they recommend to their clients every day. MarketBeat identified five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aehr Test Systems was not on the list.
Although Aehr Test Systems currently has a hold rating among analysts, top analysts believe these five stocks are the best.
View Five Stocks Here
The AI wave will soon hit the public markets with Anthropic and OpenAI slated to go public later this year. However, you don’t have to wait to invest. This report highlights seven AI stocks to buy today as major model providers prepare to go public.
Get This Free Report
